Closed · W81XWH-10-BCRP-TVA · CFDA 12.420 · Discretionary
DoD Breast Cancer Transformative Vision Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- June 23, 2010
- Close date
- 3
- Expected awards
The verdict
DoD Breast Cancer Transformative Vision Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 3
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Breast Cancer Transformative Vision Award is closed (last close June 23, 2010). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 23, 2010
Est. Total Funding
$9,000,000
Expected Awards
3
Instrument
Grant
Description
vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible. The critical components of this award mechanism are:Vision: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described.Implementation: The vision must be supported by a detailed plan that identifies critical milestones and clearly outlines the innovations and technical solutions that will be implemented to accomplish the milestones. It is expected that the proposed plan will present an exceptional level of innovation and creativity, and that the Principal Investigator (PI) will assemble the team necessary to realize the vision. The PI should have demonstrated experience in successfully leading large, focused projects. The scope of the research effort may include a broad spectrum of research spanning from basic to clinical studies, with the end result leading to a revolutionary impact on an area of paramount importance in breast cancer prevention or treatment.The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision.
Catch-all / unrestricted eligibility mark · W81XWH-10-BCRP-TVA
Grants.gov marks DoD Breast Cancer Transformative Vision Award with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Breast Cancer Transformative Vision Award is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |